The current pregnant women living with hiv antiretroviral therapy coverage for pmtct of Panama is 74%, this is a decrease of 10% (-11.9%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Panama
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Panama
PMTCT antiretroviral therapy coverage
More indicators for Panama
Male unintentional poisoning
0.1
0.0
(2019)
Female wasting in children
0.9%
-0.5%
(2019)
Female prevalence of HIV
0.2%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar1,153
+intl dollar2
(2021)
Birth registration
96.7%
+1.1%
(2019)
Contraceptive modern method prevalence
46.9%
-13.4%
(2015)
Panama PMTCT antiretroviral therapy coverage between 2000 and 2022
Period | PMTCT antiretroviral therapy coverage | Change |
---|---|---|
2022 | 74% | -10% |
2021 | 84% | +21% |
2020 | 63% | -2% |
2019 | 65% | -9% |
2018 | 74% | -6% |
2017 | 80% | +5% |
2016 | 75% | -7% |
2015 | 82% | +7% |
2014 | 75% | -13% |
2013 | 88% | +12% |
2012 | 76% | -2% |
2011 | 78% | +10% |
2010 | 68% | 0% |
2009 | 68% | +5% |
2008 | 63% | +21% |
2007 | 42% | -15% |
2006 | 57% | -2% |
2005 | 59% | +35% |
2004 | 24% | -2% |
2003 | 26% | -1% |
2002 | 27% | +4% |
2001 | 23% | +7% |
2000 | 16% |